Do Not Give Bromfed to a 23-Month-Old Child
Bromfed (brompheniramine/pseudoephedrine/dextromethorphan) should not be given to a 23-month-old child due to lack of efficacy and significant safety concerns, including reported fatalities in this age group. 1
Why This Medication Is Dangerous for Young Children
Lack of Efficacy
- Controlled trials have demonstrated that antihistamine-decongestant combination products are not effective for treating upper respiratory symptoms in young children 1
- The efficacy of cough and cold medications has not been established for children younger than 6 years 1
Serious Safety Concerns
Mortality data is particularly alarming:
- Between 1969-2006, there were 9 fatalities specifically associated with brompheniramine in children under 6 years, with 41 total antihistamine-related deaths reported below age 2 years 1
- 46 deaths were associated with pseudoephedrine in children ≤6 years, with 43 occurring in infants below age 1 year 1
- Fatal cases have been documented even with combination products containing these exact ingredients 2, 3
Common mechanisms of fatal overdose include:
- Use of multiple cold/cough products simultaneously
- Medication dosing errors by caregivers
- Accidental exposures by unsupervised children
- Intentional misuse (sedation or harm) 1, 3
Specific Toxicity Concerns for Each Component
Pseudoephedrine (decongestant):
- Can cause agitated psychosis, ataxia, hallucinations, and death in infants and young children 1, 4
- May produce tachyarrhythmias, insomnia, and hyperactivity even at recommended doses 1
- Blood levels of 14.4 mg/L have been associated with infant fatality 2
Brompheniramine (antihistamine):
- Blood concentrations as low as 0.40 mg/L have been implicated in infant deaths 2
- A 2½-year-old survived 300-900 mg, but this demonstrates unpredictable individual responses 5
- Central nervous system effects range from depression to stimulation, particularly in children 5
Dextromethorphan (cough suppressant):
- Toxic doses cause drowsiness, ataxia, nystagmus, and convulsive seizures 5
- Seizures reported in children after ingesting only 13-17 mg/kg 5
- Blood concentrations of 0.50 mg/L associated with infant fatality 2
FDA and Professional Society Recommendations
The FDA label for Bromfed explicitly states:
- "Safety and effectiveness in pediatric patients below the age of 6 months have not been established" 5
- The product is "contraindicated in nursing mothers" due to higher risk of intolerance in small infants 5
Professional guidelines are unequivocal:
- In October 2007, the FDA's Nonprescription Drugs and Pediatric Advisory Committees recommended that OTC cough and cold medications no longer be used for children below 6 years of age 1
- Major manufacturers (Wyeth, Novartis, Prestige Brands, Johnson & Johnson) voluntarily removed cough and cold medications for children under age 2 from the market 1
What to Use Instead
For a 23-month-old child with cold symptoms, consider:
Safe Alternatives with Proven Safety Profiles
- Second-generation antihistamines (cetirizine, loratadine) have been shown to be well tolerated with very good safety profiles in young children 1
- These are appropriate if allergic rhinitis is the underlying cause
For Acute Cough
- Honey (for children ≥12 months) may offer relief and is safer than OTC medications 6
- Supportive care and observation are preferred over pharmacologic intervention 6
For Nasal Congestion
- Intranasal corticosteroids are the most effective medication class for rhinitis symptoms 1
- Saline nasal irrigation
- Humidified air
Critical Pitfalls to Avoid
Never assume "a little bit won't hurt" - Individual responses are unpredictable, and even small amounts have caused serious toxicity 5
Do not use multiple products simultaneously - This was a common factor in fatal overdoses 1
Avoid using these medications for sedation - This accounted for 17.5% of fatalities in one surveillance study 3
Remember that most childhood coughs are self-limited - The natural history of viral upper respiratory infections is resolution without specific treatment 6, 7